Sildenafil/Tadalafil Recall: Mojo Max Fusion XXX
FDA recalls Mojo Max Fusion XXX capsules marketed without an approved NDA/ANDA and containing undeclared sildenafil (13.1 mg per capsule) and tadalafil (13.8 mg per capsule). The recall covers all lots with expiration date 12/31/2027 and nationwide distribution in the United States. No corrective action is specified in the recall notice.
| Brand | Mohamed Hagar |
|---|---|
| Product | Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0 |
| Reason | Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule). |
| Severity | critical |
| Units affected | 125 |
| Distribution | U.S. Nationwide |
| Agency | FDA |
WHAT YOU SHOULD DO
- Stop using Mojo Max Fusion XXX immediately.
- Dispose of the product or return it to the place of purchase for a refund.
- Refer to the recall notice for instructions and contact the distributor for more information; seek medical advice if you have health concerns after exposure.
How to identify the recalled item
| Lot / date codes | ALL LOTS, exp 12/31/2027 |
|---|---|
| Lot / date codes | ALL LOTS, exp 12/31/2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.